NR4A1 and neoplasm: In the melanoma tumor microenvironment, T-cell receptor (TCR) signaling can trigger its downstream NR4A1 expression, so using NR4A1-GFP indicated that blocking β-AR signaling increased metabolic reprogramming of CD8+ T-cell activation via TCR signaling.